IDEXX LABORATORIES INC /DE 4
4 · IDEXX LABORATORIES INC /DE · Filed Dec 2, 2015
Insider Transaction Report
Form 4
CRAIG THOMAS
Director
Transactions
- Exercise/Conversion
Common Stock
2015-11-30$17.18/sh+7,000$120,295→ 29,048 total - Sale
Common Stock
2015-11-30$70.28/sh−7,000$491,960→ 22,048 total - Exercise/Conversion
Non-Qualified Stock Option (right-to-buy)
2015-11-30−7,000→ 2,054 totalExercise: $17.18Exp: 2016-02-13→ Common Stock (7,000 underlying)
Footnotes (3)
- [F1]The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $69.95 to $71.00 inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
- [F2]Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable as to 4,527 shares on February 14, 2010, without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.
- [F3]Not applicable.